Transient Ischemic Attack (TIA)
19
6
7
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (19)
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
Ambulatory Stroke Unit Treatment for Elderly Patients
Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China
Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)
Canadian TIA Score Versus ABCD2 Score in Risk Stratification of Transient Ischemic Attack (TIA)
Addressing Sleep Apnea Post-Stroke/TIA
Essential Hypotension and Allostasis Registry
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
Population-based Brest Stroke Registry
NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event
Patient and Provider Assessment of Lipid Management Registry
Influence of Stroke on the Composition of Intestinal Microbiota
PROspective Study to OPTimize thE HEALTH of Patients With TIAs (Transient Ischemic Attacks) and Stroke Admitted to the Hamad General Hospital
Targeted Management Intervention for African-American Men With TIA or Stroke
Exercise and Brain Health
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Study of Admission Versus Discharge After Transient Ischemic Attack (TIA)